[1] Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J].Cell, 2012, 149(5): 1060-1072.
[2] Asrani S K, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world[J].J Hepatol, 2019, 70(1): 151-171.
[3] Macías-Rodríguez R U, Inzaugarat M E, Ruiz-Margáin A, et al. Reclassifying hepatic cell death during liver damage: ferroptosis-a novel form of non-apoptotic cell death?[J].Int J Mol Sci, 2020, 21(5):1651.
[4] Yang W S, Stockwell B R. Ferroptosis: death by lipid peroxidation[J].Trends Cell Biol, 2016, 26(3): 165-176.
[5] Seibt T M, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication[J].Free Radic Biol Med, 2019, 133: 144-152.
[6] Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation[J].Autophagy, 2021, 17(9): 2054-2081.
[7] Magtanong L, Ko P J, Dixon S J. Emerging roles for lipids in non-apoptotic cell death[J].Cell Death Differ, 2016, 23(7): 1099-1109.
[8] Gaschler M M, Stockwell B R. Lipid peroxidation in cell death[J].Biochem Biophys Res Commun, 2017, 482(3): 419-425.
[9] Doll S, Freitas F P, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J].Nature, 2019, 575(7784): 693-698.
[10] Wu J, Wang Y, Jiang R, et al. Ferroptosis in liver disease: new insights into disease mechanisms[J].Cell Death Discov, 2021, 7(1): 276.
[11] Sato H, Tamba M, Ishii T, et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins[J].J Biol Chem, 1999, 274(17): 11455-11458.
[12] Wang L, Liu Y, Du T, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc[J].Cell Death Differ, 2020, 27(2): 662-675.
[13] Xie Y, Hou W, Song X, et al. Ferroptosis: process and function[J].Cell Death Differ, 2016, 23(3): 369-379.
[14] Camaschella C. Iron and hepcidin: a story of recycling and balance[J].Hematology Am Soc Hematol Educ Program, 2013, 2013: 1-8.
[15] Friedmann Angeli J P, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice[J].Nat Cell Biol, 2014, 16(12): 1180-1191.
[16] Yan B, Ai Y, Sun Q, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1[J].Mol Cell, 2021, 81(2): 355-369.e310.
[17] Stockwell B R, Friedmann Angeli J P, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J].Cell, 2017, 171(2): 273-285.
[18] Gautheron J, Gores G J, Rodrigues C M P. Lytic cell death in metabolic liver disease[J].J Hepatol, 2020, 73(2): 394-408.
[19] Tong J, Li D, Meng H, et al. Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease[J].Acta Pharm Sin B, 2022, 12(9): 3650-3666.
[20] Gao G, Xie Z, Li E W, et al. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis[J].J Nat Med, 2021, 75(3): 540-552.
[21] Roeb E. Matrix metalloproteinases and liver fibrosis (translational aspects)[J].Matrix Biol, 2018, 68-69: 463-473.
[22] Li X, Duan L, Yuan S, et al. Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1[J].J Inflamm (Lond), 2019, 16: 11.
[23] Yuan S, Wei C, Liu G, et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway[J].Cell Prolif, 2022, 55(1): e13158.
[24] Wu A, Feng B, Yu J, et al. Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis[J].Redox Biol, 2021, 46: 102131.
[25] Zhao T, Yu Z, Zhou L, et al. Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice[J].Cell Death Discov, 2022, 8(1): 380.
[26] Lin F, Chen W, Zhou J, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury[J].Cell Death Dis, 2022, 13(3): 271.
[27] Zhai H, Zhong S, Wu R, et al. Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma[J].Epigenetics, 2023, 18(1):2192438.
[28] Yamada N, Karasawa T, Wakiya T, et al. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: potential role of ferroptosis[J].Am J Transplant, 2020, 20(6): 1606-1618.
[29] Guo J, Song Z, Yu J, et al. Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia/reperfusion injury via suppressing GPX4-mediated ferroptosis[J].Cell Death Dis, 2022, 13(12): 1072.
[30] Chen Q, Zheng W, Guan J, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma[J].Cell Death Differ, 2023, 30(1): 137-151.
[31] Yuan Z, Liu T, Huo X, et al. Glutamine transporter SLC1A5 regulates ionizing radiation-derived oxidative damage and ferroptosis[J].Oxid Med Cell Longev, 2022, 2022: 3403009.
[32] Wang Q, Guo Y, Wang W, et al. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA[J].Exp Cell Res, 2021, 399(1): 112453.
[33] Byun J K, Lee S, Kang G W, et al. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma[J].J Exp Clin Cancer Res, 2022, 41(1): 98.
[34] Cao F, Luo A, Yang C. G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase[J].Cell Signal, 2021, 87: 110098.
[35] Ndiaye H, Liu J Y, Hall A, et al. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases[J].Biosci Rep, 2020, 40(4):BSR20200219.
[36] Grube J, Woitok M M, Mohs A, et al. ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression[J].Cell Death Dis, 2022, 13(8): 704. |
